PROCEPT BioRobotics (PRCT) Misses Q4 EPS by 21c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
TD Cowen on Procept BioRobotics Corp (PRCT): 'We are constructive after the big stock decline'
February 26, 2026 3:05 PM ESTTD Cowen analyst Joshua Jennings reiterated a Buy rating and $34.00 price target on Procept BioRobotics Corp (NASDAQ: PRCT).
The analyst comments "We are constructive after the big stock decline that followed the Q4 report. PRCT again made a strong case to justify its recent... More
